Report Detail
Global Non-Invasive Cancer Diagnostics Market Insights, Forecast to 2025
- RnM3492156 |
- 04 June, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
Global non invasive cancer diagnostics and technologies market is anticipated to show lucrative growth over the forecast period owing to factor such as rising demand for minimally invasive therapeutics and diagnosis for the treatment of cancer. Moreover, increasing prevalence of cancer because of rising aging population and unhealthy lifestyle is also important factor that is fueling the growth of this market. Commercialization of non invasive cancer diagnostics and technologies is expected to grow owing to completion of human genome project (HGP) which will help in identifying chemical base pairs which make up DNA, hence opening avenues for market players. Rising awareness amongst people about the advantages of early diagnosis and treatment of cancer has led to a hike in number of people undergoing diagnosis. Furthermore, growing research and development in cancer diagnosis and treatment is another factor that is boosting the growth. Advancements in cancer detection technologies like cancer biomarkers and fluorescence in situ hybridization (FISH) technique are also expected to contribute towards the growth of this market.
The global non invasive cancer diagnostics and technologies market is segmented into type and technology. Based on type this market is further sub segmented into breast cancer, blood cancer, lung cancer and solid tumors. Breast cancer held the largest share in 2014 owing to factor such as increasing incidence of breast cancer. Moreover, rising awareness amongst people about symptoms, diagnosis and therapies about breast cancer has contributed towards the dominance of this segment. Also, government and non-government organization’s (NGO) initiatives to create awareness about breast cancer early diagnosis and treatment are also helping to grow this market. Breast cancer segment is also expected to witness lucrative growth over the coming seven years as a consequence of advancements like lumpectomy and partial mastectomy. Based on technology the market is segmented into immunochemistry, molecular diagnosis and clinical chemistry. Molecular diagnostic market held the largest share in 2014 as a consequence of various advantages associated to it. These advantages include high precision of diagnosis such as high specificity, high sensitivity, and rapid turnaround time.
The global Non-Invasive Cancer Diagnostics market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Non-Invasive Cancer Diagnostics market based on company, product type, end user and key regions.
This report studies the global market size of Non-Invasive Cancer Diagnostics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Non-Invasive Cancer Diagnostics in these regions.
This research report categorizes the global Non-Invasive Cancer Diagnostics market by top players/brands, region, type and end user. This report also studies the global Non-Invasive Cancer Diagnostics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Gen-Probe Inc
Digene Corporation
Quest Diagnostics Inc
Cancer, Genetics Inc
BIOVIEW Inc
AVIVA Biosciences Corporation
Laboratory Corporation of America Holdings (LabCorp)
A&G Pharmaceutical
Affymetrix Inc
Precision Therapeutics
Market size by Product
CTCs
CTNAS
Exosomes
Market size by End User
Blood
Urine
Saliva
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Non-Invasive Cancer Diagnostics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Non-Invasive Cancer Diagnostics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Non-Invasive Cancer Diagnostics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Non-Invasive Cancer Diagnostics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Non-Invasive Cancer Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Non-Invasive Cancer Diagnostics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Non-Invasive Cancer Diagnostics Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by Product
- 1.4.2 CTCs
- 1.4.3 CTNAS
- 1.4.4 Exosomes
- 1.5 Market by End User
- 1.5.1 Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by End User
- 1.5.2 Blood
- 1.5.3 Urine
- 1.5.4 Saliva
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Non-Invasive Cancer Diagnostics Market Size
- 2.1.1 Global Non-Invasive Cancer Diagnostics Revenue 2014-2025
- 2.1.2 Global Non-Invasive Cancer Diagnostics Sales 2014-2025
- 2.2 Non-Invasive Cancer Diagnostics Growth Rate by Regions
- 2.2.1 Global Non-Invasive Cancer Diagnostics Sales by Regions
- 2.2.2 Global Non-Invasive Cancer Diagnostics Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Non-Invasive Cancer Diagnostics Sales by Manufacturers
- 3.1.1 Non-Invasive Cancer Diagnostics Sales by Manufacturers
- 3.1.2 Non-Invasive Cancer Diagnostics Sales Market Share by Manufacturers
- 3.1.3 Global Non-Invasive Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
- 3.2 Non-Invasive Cancer Diagnostics Revenue by Manufacturers
- 3.2.1 Non-Invasive Cancer Diagnostics Revenue by Manufacturers (2014-2019)
- 3.2.2 Non-Invasive Cancer Diagnostics Revenue Share by Manufacturers (2014-2019)
- 3.3 Non-Invasive Cancer Diagnostics Price by Manufacturers
- 3.4 Non-Invasive Cancer Diagnostics Manufacturing Base Distribution, Product Types
- 3.4.1 Non-Invasive Cancer Diagnostics Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Non-Invasive Cancer Diagnostics Product Type
- 3.4.3 Date of International Manufacturers Enter into Non-Invasive Cancer Diagnostics Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Non-Invasive Cancer Diagnostics Sales by Product
- 4.2 Global Non-Invasive Cancer Diagnostics Revenue by Product
- 4.3 Non-Invasive Cancer Diagnostics Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Non-Invasive Cancer Diagnostics Breakdown Data by End User
6 North America
- 6.1 North America Non-Invasive Cancer Diagnostics by Countries
- 6.1.1 North America Non-Invasive Cancer Diagnostics Sales by Countries
- 6.1.2 North America Non-Invasive Cancer Diagnostics Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Non-Invasive Cancer Diagnostics by Product
- 6.3 North America Non-Invasive Cancer Diagnostics by End User
7 Europe
- 7.1 Europe Non-Invasive Cancer Diagnostics by Countries
- 7.1.1 Europe Non-Invasive Cancer Diagnostics Sales by Countries
- 7.1.2 Europe Non-Invasive Cancer Diagnostics Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Non-Invasive Cancer Diagnostics by Product
- 7.3 Europe Non-Invasive Cancer Diagnostics by End User
8 Asia Pacific
- 8.1 Asia Pacific Non-Invasive Cancer Diagnostics by Countries
- 8.1.1 Asia Pacific Non-Invasive Cancer Diagnostics Sales by Countries
- 8.1.2 Asia Pacific Non-Invasive Cancer Diagnostics Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Non-Invasive Cancer Diagnostics by Product
- 8.3 Asia Pacific Non-Invasive Cancer Diagnostics by End User
9 Central & South America
- 9.1 Central & South America Non-Invasive Cancer Diagnostics by Countries
- 9.1.1 Central & South America Non-Invasive Cancer Diagnostics Sales by Countries
- 9.1.2 Central & South America Non-Invasive Cancer Diagnostics Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Non-Invasive Cancer Diagnostics by Product
- 9.3 Central & South America Non-Invasive Cancer Diagnostics by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Non-Invasive Cancer Diagnostics by Countries
- 10.1.1 Middle East and Africa Non-Invasive Cancer Diagnostics Sales by Countries
- 10.1.2 Middle East and Africa Non-Invasive Cancer Diagnostics Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Non-Invasive Cancer Diagnostics by Product
- 10.3 Middle East and Africa Non-Invasive Cancer Diagnostics by End User
11 Company Profiles
- 11.1 Gen-Probe Inc
- 11.1.1 Gen-Probe Inc Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Gen-Probe Inc Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Gen-Probe Inc Non-Invasive Cancer Diagnostics Products Offered
- 11.1.5 Gen-Probe Inc Recent Development
- 11.2 Digene Corporation
- 11.2.1 Digene Corporation Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Digene Corporation Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Digene Corporation Non-Invasive Cancer Diagnostics Products Offered
- 11.2.5 Digene Corporation Recent Development
- 11.3 Quest Diagnostics Inc
- 11.3.1 Quest Diagnostics Inc Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Products Offered
- 11.3.5 Quest Diagnostics Inc Recent Development
- 11.4 Cancer, Genetics Inc
- 11.4.1 Cancer, Genetics Inc Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Products Offered
- 11.4.5 Cancer, Genetics Inc Recent Development
- 11.5 BIOVIEW Inc
- 11.5.1 BIOVIEW Inc Company Details
- 11.5.2 Company Business Overview
- 11.5.3 BIOVIEW Inc Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 BIOVIEW Inc Non-Invasive Cancer Diagnostics Products Offered
- 11.5.5 BIOVIEW Inc Recent Development
- 11.6 AVIVA Biosciences Corporation
- 11.6.1 AVIVA Biosciences Corporation Company Details
- 11.6.2 Company Business Overview
- 11.6.3 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Products Offered
- 11.6.5 AVIVA Biosciences Corporation Recent Development
- 11.7 Laboratory Corporation of America Holdings (LabCorp)
- 11.7.1 Laboratory Corporation of America Holdings (LabCorp) Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Products Offered
- 11.7.5 Laboratory Corporation of America Holdings (LabCorp) Recent Development
- 11.8 A&G Pharmaceutical
- 11.8.1 A&G Pharmaceutical Company Details
- 11.8.2 Company Business Overview
- 11.8.3 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Products Offered
- 11.8.5 A&G Pharmaceutical Recent Development
- 11.9 Affymetrix Inc
- 11.9.1 Affymetrix Inc Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Affymetrix Inc Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Affymetrix Inc Non-Invasive Cancer Diagnostics Products Offered
- 11.9.5 Affymetrix Inc Recent Development
- 11.10 Precision Therapeutics
- 11.10.1 Precision Therapeutics Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Precision Therapeutics Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Precision Therapeutics Non-Invasive Cancer Diagnostics Products Offered
- 11.10.5 Precision Therapeutics Recent Development
12 Future Forecast
- 12.1 Non-Invasive Cancer Diagnostics Market Forecast by Regions
- 12.1.1 Global Non-Invasive Cancer Diagnostics Sales Forecast by Regions 2019-2025
- 12.1.2 Global Non-Invasive Cancer Diagnostics Revenue Forecast by Regions 2019-2025
- 12.2 Non-Invasive Cancer Diagnostics Market Forecast by Product
- 12.2.1 Global Non-Invasive Cancer Diagnostics Sales Forecast by Product 2019-2025
- 12.2.2 Global Non-Invasive Cancer Diagnostics Revenue Forecast by Product 2019-2025
- 12.3 Non-Invasive Cancer Diagnostics Market Forecast by End User
- 12.4 North America Non-Invasive Cancer Diagnostics Forecast
- 12.5 Europe Non-Invasive Cancer Diagnostics Forecast
- 12.6 Asia Pacific Non-Invasive Cancer Diagnostics Forecast
- 12.7 Central & South America Non-Invasive Cancer Diagnostics Forecast
- 12.8 Middle East and Africa Non-Invasive Cancer Diagnostics Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Non-Invasive Cancer Diagnostics Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Non-Invasive Cancer Diagnostics . Industry analysis & Market Report on Non-Invasive Cancer Diagnostics is a syndicated market report, published as Global Non-Invasive Cancer Diagnostics Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Non-Invasive Cancer Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
